Amanda Saulean
Executive Director, Alternative Investments, Morgan Stanley · Morgan Stanley
Andrew McDougall
US Chief Investment Officer, Marsh · Marsh
Anya Coverman
President & CEO · Institute for Portfolio Alternatives
Benjamin Oakes
Co-founder, President and CEO, Scribe Therapeutics · Scribe Therapeutics
Benjamin Wells
Partner, Simpson Thacher & Bartlett LLP · Simpson Thacher & Bartlett LLP
Bill Duffy
Head of Alternative Investment Platform Solutions, Fidelity · Fidelity
Bob Long
Chief Executive Officer, StepStone Group · StepStone Group
Brendan Cuddihy
IPA Chair Elect, Chief Operating Officer · CAIS
Chip Roame
Founder and Managing Partner · Tiburon Strategic Advisors
Chris Donahoe
Co-founder & Head of AI, Stillpoint Global Advisors · Stillpoint Global Advisors
Chris Healey
Partner, Davis Polk · Davis Polk
Chris Zuczek
Chief Product Officer, CAIS · CAIS
Dana Petitto
Chief Operating Officer and Portfolio Manager, Brookfield · Brookfield
Dan Beck
Vice President of Brokerage Solutions, SS&C · SS&C
David Perechocky
Partner, Gibson Dunn · Gibson Dunn
David Warren
Co-Founder and Chairman, Bridgeford Trust Company · Bridgeford Trust Company
Dayna Kleinman
Managing Director, Head of US Wealth, Sagard · Sagard
Donald Hall
Managing Director, Portfolio Manager & Global Head of Research, Nuveen · Nuveen
Doug Krupa
Partner · KKR & Co.
Frank Cordio
Executive Director, Hightower Advisors · Hightower Advisors
Frank Heavey
Executive Director, Expect Miracles Foundation · Expect Miracles Foundation
Gordon Ross
Managing Director, DeVoe & Company · DeVoe & Company